T-3:A Multicenter Phase IB Dose Escalation Study to Evaluate the Safety, Feasibility and Efficacy of the Temsirolimus (Torisel (TM))-CHOP-Rituximab (T-R-CHOP), Temsirolimus (Torisel (TM))-FC-Rituximab (T-R-FC) and Temsirolimus (Torisel (TM))-DHA-Rituximab
| Affiliation auteurs | Affiliation ok |
| Titre | T-3:A Multicenter Phase IB Dose Escalation Study to Evaluate the Safety, Feasibility and Efficacy of the Temsirolimus (Torisel (TM))-CHOP-Rituximab (T-R-CHOP), Temsirolimus (Torisel (TM))-FC-Rituximab (T-R-FC) and Temsirolimus (Torisel (TM))-DHA-Rituximab |
| Type de publication | Journal Article |
| Year of Publication | 2014 |
| Auteurs | Le Gouill S, Bouabdallah K, Cartron G, Gressin R, Lamy T, Coiffier B, Thieblemont C, Haioun C, Casasnovas O, Gyan E, Hermine O |
| Journal | BLOOD |
| Volume | 124 |
| Date Published | DEC 6 |
| Type of Article | Meeting Abstract |
| ISSN | 0006-4971 |